Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2013
11/28/2013WO2013174863A1 Chondroitin for use in medicine
11/28/2013WO2013174854A1 Terpene extract for the treatment of hair loss
11/28/2013WO2013174847A1 Low -molecular -weight biotechnological chondroitin 6 - sulphate for prevention of osteoarthritis
11/28/2013WO2013174822A1 Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group ii metabotropic glutamate receptors
11/28/2013WO2013174781A1 5-amino[1,4]thiazines as bace 1 inhibitors
11/28/2013WO2013174780A1 Substituted dipyridylamines and uses thereof
11/28/2013WO2013174768A1 A xanthine derivative as dpp -4 inhibitor for use in the treatment of autoimmune diabetes, particularly lada
11/28/2013WO2013174767A1 A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
11/28/2013WO2013174757A1 Tertiary amines, medicaments containing said amines, use thereof and processes for the preparation thereof
11/28/2013WO2013174744A1 Thienopyrimidines
11/28/2013WO2013174743A1 Substituted pyrrolopyrimidines
11/28/2013WO2013174736A1 N-[3-(2-carboxyethyl)phenyl]piperidin-1-ylacetamide derivatives and use thereof as activators of soluble guanylate cyclase
11/28/2013WO2013174735A1 Substituted benzothienopyrimidines
11/28/2013WO2013174692A1 Therapeutic micro rna targets in chronic pulmonary diseases
11/28/2013WO2013174645A1 N-thio-anthranilamide compounds and their use as pesticides
11/28/2013WO2013174508A1 Novel 1,3-benzoxazol-2(3h)-ones and their use as medicaments and cosmetics
11/28/2013WO2013174498A1 Dosage forms comprising apixaban and matrix former
11/28/2013WO2013174485A1 SUBSTITUTED ß-AMINO ACID DERIVATIVES AS CXCR3 RECEPTOR ANTAGONISTS
11/28/2013WO2013174245A1 Hederagenin derivative and preparation method and uses thereof
11/28/2013WO2013174207A1 Protein tyrosine phosphatase inhibitor, preparation method and uses thereof
11/28/2013WO2013174133A1 Application of sbt in preventing and treating diabetes mellitus vasculopathy and neuropathy
11/28/2013WO2013174017A1 Method for preparing fully protection heparin pentasaccharide and intermediate thereof
11/28/2013WO2013174015A1 Cefixime granule and preparation method thereof
11/28/2013WO2013173881A1 A dermatological composition
11/28/2013WO2013173862A1 Improved synthesis
11/28/2013WO2013173859A1 A method of improving liver function
11/28/2013WO2013173858A1 A method of weight reduction
11/28/2013WO2013152065A3 1,8-naphthyridin-2(1h)-one derivatives as cytomegalovirus inhibitors
11/28/2013WO2013150529A3 Indole, indoline derivatives, compositions comprising them and uses thereof
11/28/2013WO2013131089A3 Potent anticancer activity via dual compound activation
11/28/2013WO2013126550A3 Antimicrobial compositions, the preparation and use thereof
11/28/2013WO2013122375A9 Pharmaceutical composition for viral treatment, and method for screening antiviral agent
11/28/2013WO2013117789A3 Formylated xanthocillin analogues as neuroprotectants
11/28/2013WO2013111161A3 Process for the preparation of 3-aryl-2-methyl-propanamine derivatives and polymorphs thereof
11/28/2013WO2012156877A8 Treating skin exposed to uv radiation with quetiapine or analogs thereof
11/28/2013WO2012125828A8 Methods of treating breast cancer with anthracycline therapy
11/28/2013WO2012118729A3 Medicament delivery device for administration of opioid antagonists including formulations for naloxone
11/28/2013WO2012068531A3 Novel compositions and uses of anti-hypertension agents for cancer therapy
11/28/2013WO2009099999A3 Methods and compositions for treatment for coronary and arterial aneurysmal subarachnoid hemorrhage
11/28/2013US20130317462 Transdermal delivery system for hormones and steroids
11/28/2013US20130317457 Aqueous Pharmaceutical Composition Containing A Biologic Therapeutic Agent And Guanidine Or A Guanidine Derivative And An Injection Including The Composition
11/28/2013US20130317226 INHIBITORS OF THE INTERACTION OF THE SIGMA-1 RECEPTOR WITH hERG FOR USE IN THE TREATMENT OF CANCER
11/28/2013US20130317216 2,4-pyrimidinediamine compounds and their uses
11/28/2013US20130317115 Composition and Method for Treating Neurological Disease
11/28/2013US20130317113 Regulation of osteopontin
11/28/2013US20130317112 Storage-stable formulation of paracetamol in aqueous solution
11/28/2013US20130317110 Compound, kinesin spindle protein inhibitor, and application thereof
11/28/2013US20130317108 Dermatological foams obtained from a gel or suspension containing a combination of adapalene and benzoyl peroxide
11/28/2013US20130317107 Platelet-Based Methods to Detect and Monitor Treatment Benefits in Mucosal and Nervous Systems Diseases
11/28/2013US20130317100 Process for the preparation of 3-aroyl-5-aminobenzofuran derivatives
11/28/2013US20130317099 Picropodophyllin Polymorphs B or C for Use in Cancer Therapy
11/28/2013US20130317097 Stable compositions of dehydroascorbic acid
11/28/2013US20130317096 Synergistic interaction of at least one vitamin e component and tyrosinase inhibitors for dermatological applications
11/28/2013US20130317094 Use of ellagitannins as inhibitors of bacterial quorum sensing
11/28/2013US20130317093 Methods of treating alzheimer's disease with apo a-1 milano
11/28/2013US20130317092 Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial
11/28/2013US20130317088 Selective Reduction of the Deleterious Activity of Extended Tri-Nucleotide Repeat Containing Genes
11/28/2013US20130317086 Neural transfection reagents
11/28/2013US20130317084 Method of treating diabetes
11/28/2013US20130317078 Phenylalkyl n-hydroxyureas for treating leukotriene related pathologies
11/28/2013US20130317076 Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and a Salicylic Acid Component
11/28/2013US20130317075 Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and a NSAR
11/28/2013US20130317072 Method To Enhance Delivery Of Glutathione And ATP Levels In Cells
11/28/2013US20130317071 Novel compounds that are useful for improving pharmacokinetics
11/28/2013US20130317070 Compositions and methods for treating tuberculosis
11/28/2013US20130317065 Indole derivative and pharmacologically acceptable salt thereof
11/28/2013US20130317063 Oral controlled release pharmaceutical compositions of bepotastine
11/28/2013US20130317058 Ophthalmic composition for enabling dilation of pupils
11/28/2013US20130317057 Aldosterone synthase inhibitors
11/28/2013US20130317055 Neuronal nicotinic agonist and methods of use
11/28/2013US20130317053 Externally-used drug for treating skin disorder and method for producing same
11/28/2013US20130317051 Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
11/28/2013US20130317050 Methods for treatment and prevention of opioid induced constipation using oral compositions of methylnaltrexone
11/28/2013US20130317049 Methods Useful for the Treatment of Pain, Arthritic Conditions or Inflammation Associated with a Chronic Condition
11/28/2013US20130317048 Combination comprising paclitaxel for treating ovarian cancer
11/28/2013US20130317047 Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure
11/28/2013US20130317046 Use of a dpp-4 inhibitor in autoimmune diabetes, particularly lada
11/28/2013US20130317045 Thienopyridine and thienopyrimidine compounds and methods of use thereof
11/28/2013US20130317044 Novel carboxylic acid derivatives, their preparation and use
11/28/2013US20130317043 Compounds and Methods for Treating Autoimmune Diseases
11/28/2013US20130317042 Method of Treating Ischemia/Reperfusion Injury
11/28/2013US20130317040 Methods for treating systemic lupus erythematosus using hiv protease inhibitors
11/28/2013US20130317038 Method of treating atrial fibrillation
11/28/2013US20130317037 Method of administration and treatment
11/28/2013US20130317036 Folic acid - ramipril combination: cellprotective, neuroprotective and retinoprotective ophtalmologic compositions
11/28/2013US20130317035 Novel opioid antagonists
11/28/2013US20130317034 Combination therapy for treating diabetes
11/28/2013US20130317033 Substituted triazolo-pyridazine derivatives
11/28/2013US20130317032 Thiazole and thiadiazole compounds for inflammation and immune-related uses
11/28/2013US20130317031 Nuclear Transport Modulators And Uses Thereof
11/28/2013US20130317025 Pde-10 inhibitors
11/28/2013US20130317024 Pyrrolopyrrolidinone compounds
11/28/2013US20130317022 7-oxo-thiazolopyridine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
11/28/2013US20130317021 Heterocyclic pyrimidine carbonic acid derivatives which are useful in the treatment, amelioration or prevention of a viral disease
11/28/2013US20130317019 A2A Antagonists as Cognition and Motor Function Enhancers
11/28/2013US20130317018 Methods and Compositions for Unsilencing Imprinted Genes
11/28/2013US20130317016 Aprepitant Injectable Formulations
11/28/2013US20130317013 Ep4 receptor agonist, compositions and methods thereof
11/28/2013US20130317009 Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and an Anticonvulsant
11/28/2013US20130317008 Use of a Specific Cyclic Amine Derivative or the Pharmaceutically Acceptable Salts Thereof for the Treatment or Prevention of Heart Failure
1 ... 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 ... 7860